LEDAS Blog
The field of digital medicine is the top grossing one for LEDAS. In the past 3-5 years, it has grown to represent close to one-third of our income. We have completed more than ten digital medical projects in different areas for the desktop and Web/cloud, and in the coming years we plan to broaden our portfolio in digital health solutions even further.
And so it was that in Jerusalem on 9-10 November, LEDAS took part in MIXiii, the annual Life Science & Health Tech Industries event for Israel. Our interest in MIXiii is explained by a LinkedIn article written by LEDAS founder David Levin we recently posted, “LEDAS covers 5 of 7 areas currently having highest potential in digital medicine: Orthopedics, Plastic & Reconstructive Surgery, Prostheses, Orthoses, and ...
Deciding Which is Better: Plug-ins or Applications
Nov 08, 2021Many of LEDAS’ projects are developed as plug-ins for CAD software programs, ranging from powerful systems like CATIA to lighter weight solutions like Rhino. Oftimes, we help our customers decide on which direction their ideas are best developed: in the form of a plug-in or as a standalone program.
In this post, I reflect on why and when plug-in development is the better approach compared to building an application from scratch. I’ll also talk about the forms of plug-in that are useful in different situations. Learn more about our CAD plug-in development expertise.
Pros and cons of plug-ins
Plug-ins either solve specific problems or add functions that are missing from CAD systems. A good example is CAMWorks from HCL, an ...
What Statistics Can Tell Us About SARS-CoV-2 Test Results
Antibody testing at LEDAS shows good results. What does it mean?
Jul 20, 2020To better estimate the situation with СOVID-19 within our company LEDAS, we decided to make antibody testing available to our employees who work remotely since March. Fifty-three of our 70+ employees were interested, and so we organized out-of-lab testing thanks to Invitro’s laboratory service. Both IgM (early antibodies) and IgG (late antibodies) were examined, and the results were simple: all had zero positives for IgM, and one employee was positive for IgG.
We were able to congratulate ourselves for the zero result in early antibodies, meaning we are quite safe. But now we needed to focus on the late antibodies, as they provide more interesting information. Since we at LEDAS are now involved in more medical software projects, we considered this an opportunity to apply statistics to our ...
LEDAS customer map
May 24, 2020The geography of the locations of our customers has changed considerably during the 20+ years of LEDAS’ history.
From looking at the map of our customers (below), you may think that we began in our home country and then expanded abroad. In fact, the reverse is true, because in its first years LEDAS mostly provided CAD and CAM software development services in Europe, namely to Dassault Systèmes from France.
In the beginning, we concentrated on developing geometric solvers and engines, a rather narrow field, yet very sensitive to quality. Over the following years, overall CAD software market was our primary focus.
In late 2000s, LEDAS Geometric Solver (LGS) was our flagship product, along with our high-quality R&D (research and development) services for CAD and PLM. Many ...